RT UpTop.meme (@uptopmeme)Official Announcement: UPTOP has officially signed a strategic merger framework agreement with NASDAQ listed company BIYA!At 9:00 AM New York time, U.S. listed company BIYA (NASDAQ: BIYA) released news declaring the signing of a strategic merger agreement with UPTOP project owner STARFISH TECHNOLOGY-FZE, headquartered in Dubai. This marks an important milestone in our journey to realize the vision of becoming the “world’s largest decentralized liquidity infrastructure.”BIYA’s news ...

Core Points - Ikena Oncology, Inc. announced the results of its annual stockholder meeting, where stockholders approved the merger with Inmagene Biopharmaceuticals [2][3] - The combined company will be named ImageneBio, Inc. and will trade on Nasdaq under the ticker symbol "IMA" [3] - A 1-for-12 reverse stock split will be executed, reducing the number of outstanding shares from approximately 48.2 million to about 4 million [3][4] Company Overview - Ikena Oncology focuses on developing differentiated therapies targeting cancer growth, spread, and therapeutic resistance [6] - Inmagene Biopharmaceuticals is a clinical-stage biotechnology company developing therapeutics for immunological and inflammatory diseases, with its lead asset IMG-007 recently completing Phase 2a trials [5][6] Merger Details - The merger allows for the issuance of shares of Ikena's common stock to Inmagene shareholders and investors involved in the financing concurrent to the merger [3] - The reverse stock split is expected to be effective around the end of July, prior to the merger closing [3][4] - The new CUSIP number for the combined company's common stock will be 45175G 207 [3] Product Information - IMG-007 is a humanized, subcutaneously administered monoclonal antibody targeting OX40, showing promising results in clinical trials for atopic dermatitis and alopecia areata [7] - The drug demonstrated a half-life of 34.7 days, supporting infrequent dosing [7] - In clinical trials, IMG-007 exhibited sustained clinical activity and was well tolerated, with no significant adverse effects reported [7]

Core Viewpoint - Portman Ridge Finance Corporation (PTMN) has successfully completed its merger with Logan Ridge Finance Corporation (LRFC), resulting in a combined entity with total assets exceeding $600 million as of July 11, 2025 [1][3]. Company Overview - PTMN will be rebranded as BCP Investment Corporation later in the summer of 2025 to reflect its affiliation with the BC Partners Credit Platform [2][7]. - The company operates as a publicly traded, externally managed closed-end investment company regulated under the Investment Company Act of 1940, focusing on middle market investments [9]. Financial Details - LRFC shareholders will receive approximately 4.0 million shares of PTMN common stock, equating to 1.5 shares of PTMN for each LRFC share, along with cash payments for fractional shares [3]. - Prior to the merger, LRFC announced a cash payment of $0.47 per share to its shareholders, with an additional tax distribution of $0.38 per share declared on July 14, 2025 [4]. Future Initiatives - Starting in 2026, the company plans to transition to monthly base distributions while maintaining the potential for quarterly supplemental distributions, which will approximate 50% of incremental net investment income [7]. - Over the next 24 months, the company intends to repurchase up to 20% of its outstanding common stock if shares trade below 80% of net asset value (NAV), with a share price target of $15.08 based on March 31, 2025 NAV [7]. Advisory and Legal Support - Keefe, Bruyette & Woods served as the financial advisor to PTMN's Special Committee, while Houlihan Lokey acted as the financial advisor to LRFC's Special Committee [6][8].

Core Points - FARO Technologies, Inc. has announced that its shareholders approved the acquisition by AMETEK, Inc. at a Special Meeting [1][2] - Over 99% of votes cast were in favor of the merger agreement, which required a majority vote from FARO's outstanding shares [2] - Upon completion of the merger, FARO shareholders will receive $44 in cash for each share of FARO common stock, with the transaction expected to close in the second half of 2025, pending regulatory approvals [3] Company Information - FARO has been a leader in technology solutions for over 40 years, focusing on enabling customers to measure their world and make informed decisions [5] - The company is recognized for its innovative approach in bridging digital and physical realities through reliable data accuracy and immediacy [5] Advisory Information - Evercore is serving as the exclusive financial advisor, while Foley & Lardner LLP is acting as the legal advisor to FARO during this merger process [4]

Core Viewpoint - Ikena Oncology, Inc. has received recommendations from Institutional Shareholder Services Inc. and Glass, Lewis & Co. to vote in favor of the share issuance related to the proposed merger with Inmagene Biopharmaceuticals at the upcoming Annual Meeting of Stockholders on July 15, 2025 [1][2]. Company Overview - Ikena Oncology focuses on developing differentiated therapies targeting cancer growth, spread, and therapeutic resistance [6]. - Inmagene Biopharmaceuticals is a clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, with its lead asset IMG-007 recently completing a Phase 2a clinical trial in atopic dermatitis [5][6]. Product Details - IMG-007 is a humanized anti-OX40 monoclonal antibody designed to minimize safety risks and enable less frequent dosing regimens, with a half-life of 34.7 days [7]. - The drug has shown marked clinical activity and a well-tolerated safety profile in patients with moderate-to-severe atopic dermatitis during its Phase 2a trial [7]. Merger Details - The share issuance related to the merger is included in "PROPOSAL 1" of the proxy vote, alongside six additional proposals for the Annual Meeting [4]. - Stockholders as of May 22, 2025, are entitled to vote at the meeting, which will be held virtually [4]. Market Potential - The Ikena Board is optimistic about the merger with Inmagene, citing the potential of IMG-007 to create shareholder value in the immunological and inflammatory space [3].

Indonesian telecommunications tower company Dayamitra Telekomunikasi is considering reviving a merger with rival Tower Bersama Infrastructure, sources say https://t.co/ghZyBtPRvl ...

All-stock merger deals are complicated enough before mixing in AI, crypto and retail shareholders, says @hughes_chris (via @opinion) https://t.co/rFAjtiz6lS ...

Merger Overview - Uniti and Windstream are merging to create a premier fiber provider with approximately $4 billion in revenue and 240,000 fiber route miles across 47 US states[13] - Existing Uniti shareholders will own roughly 62% and Windstream shareholders will own about 38% of the combined company's common equity[13] - The combined company has approximately 44 million residential households, 240,000 fiber route miles, and 150,000 on-net locations[8] Financial Profile & Growth - The combined company anticipates core fiber revenue between $2845 million and $2865 million, and total revenue between $3745 million and $3780 million in 2025[25] - The combined company anticipates total adjusted EBITDA between $1545 million and $1575 million, and total net Capex between $1210 million and $1220 million in 2025[25] - Kinetic consumer revenue is expected to grow approximately 2% in 2025, and strategic fiber infrastructure revenue is expected to grow approximately 5% in 2025[28] - Uniti is targeting strategic recurring revenue growth of approximately 4% to 6% and strategic recurring adjusted EBITDA growth of approximately 8% to 10% in 2025[35] Strategic Priorities - Uniti aims to pass an incremental 325,000 homes with fiber in 2025, reaching approximately 2 million homes in total[35] - Consolidated new sales bookings MRR was $08 million in Q1 2025, up approximately 40% from the prior year period[49] - The company's debt yielded approximately 125% in February 2023, which has improved to approximately 75% currently[52] AI Opportunity - The total AI TAM is projected to be $300 billion by 2030, with digital infrastructure TAM at $40 billion and fiber/network TAM at $15 billion[19]

Core Viewpoint - Old Point Financial Corporation's shareholders have approved the merger with TowneBank, marking a significant step towards the completion of the transaction, which is expected to finalize in the second half of 2025, pending regulatory approvals [1][2]. Company Overview - Old Point Financial Corporation (NASDAQ: OPOF) is the parent company of Old Point National Bank and Old Point Wealth Management, serving the Hampton Roads and Richmond regions of Virginia [3]. - Old Point National Bank is a community bank offering a variety of financial services, including checking, insurance, mortgage products, and commercial lending [3]. - Old Point Wealth Management is the largest wealth management provider in Hampton Roads, focusing on local asset management [3]. Merger Details - The merger is seen as a strategic partnership that will enhance value for shareholders and support community growth [2]. - The completion of the merger is subject to customary closing conditions, including regulatory approvals [1].

Core Viewpoint - Radius Recycling, Inc. reported significant improvements in its financial performance for the third quarter of fiscal 2025, with higher sales volumes across ferrous, nonferrous, and finished steel products, leading to a notable reduction in losses compared to previous quarters [2][3][4]. Financial Performance - The company reported a loss per share from continuing operations of $(0.59) and a net loss of $(16) million for the third quarter, an improvement from $(1.15) and $(33) million in the second quarter [2][3]. - Adjusted EBITDA was $22 million in the third quarter, a significant improvement from approximately break-even in the prior quarter [3][33]. - The adjusted loss per share from continuing operations was $(0.39) in the third quarter, compared to $(0.99) in the second quarter [3][32]. Sales Volumes and Market Conditions - Nonferrous sales volumes increased by 23% sequentially, driven by strong domestic demand and higher average net selling prices, which rose by 7% [4][5]. - Ferrous sales volumes were up 4% sequentially, with average net selling prices increasing by 3% despite a volatile market environment [5][6]. - Finished steel sales volumes increased by 15% sequentially, attributed to stronger construction activity and healthy demand in Western markets [6][7]. Operational Metrics - Rolling mill utilization reached 107%, significantly higher than 88% in the prior quarter, contributing to improved operating leverage and margin expansion [6][7]. - The company generated positive operating cash flow of $3 million during the third quarter [7]. Debt and Capital Management - Total debt at the end of the quarter was $454 million, with net debt (debt minus cash) at $438 million [7][35]. - Capital expenditures for the quarter were $10 million [7]. Dividend Declaration - The Board of Directors declared a cash dividend of $0.1875 per common share, marking the 125th consecutive quarterly dividend [9][10]. Merger Activity - The company is in the process of merging with Toyota Tsusho America, Inc., with shareholder approval already obtained, and the merger expected to close in the second half of calendar year 2025, pending regulatory approvals [10][11].